Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

enVVeno Medical Corporation - Common Stock (NQ:NVNO)

0.4200 -0.2330 (-35.68%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about enVVeno Medical Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
enVVeno Medical to Participate at the Virtual Investor Ask the CEO Conference
Via ACCESSWIRE
News headline image
enVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal Trial
Via ACCESSWIRE
News headline image
enVVeno Medical Announces New Expedited Development Plan for the enVVe(R) Transcatheter Based Replacement Venous Valve
Via ACCESSWIRE
News headline image
enVVeno Medical Announces Private Placement of $28 Million
Via ACCESSWIRE
News headline image
enVVeno Medical Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
enVVeno Medical Reports First Quarter 2023 Financial Results and Provides Corporate Update
Via ACCESSWIRE
News headline image
enVVeno Medical to Present at Cowen's 43rd Annual Health Care Conference
Via ACCESSWIRE
News headline image
enVVeno Medical Successfully Passes Preliminary FDA Safety Review for the VenoValve U.S. Pivotal Study
Via ACCESSWIRE
News headline image
enVVeno Medical Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Via ACCESSWIRE
News headline image
enVVeno Medical to Host Virtual KOL Event on July 18, 2023
Via ACCESSWIRE
News headline image
enVVeno Medical Provides Enrollment Update for Ongoing VenoValve(R) U.S. Pivotal Study and Announces Upcoming Investor and KOL Events
Via ACCESSWIRE
News headline image
enVVeno Medical Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
Via ACCESSWIRE
News headline image
enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer
Via ACCESSWIRE
News headline image
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
Via ACCESSWIRE
News headline image
enVVeno Medical to Host Conference Call and Webcast on September 21, 2022
Via ACCESSWIRE
News headline image
enVVeno Medical Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Via ACCESSWIRE
News headline image
Positive 3-Year VenoValve(R) First-in-Human Data Presented at 49th Annual VEITH Symposium on Vascular and Endovascular Issues
Via ACCESSWIRE
News headline image
enVVeno Medical to Present at the Ladenburg Thalmann 2022 Healthcare Conference
Via ACCESSWIRE
News headline image
enVVeno Medical to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Via ACCESSWIRE
News headline image
enVVeno Medical Appoints Kevin Belteau as Vice President of Clinical Operations
Via ACCESSWIRE
News headline image
enVVeno Medical Announces the Issuance of a New Unique Category III CPT Code Covering the Insertion of a Bioprosthetic Valve into the Femoral Vein
IRVINE, CA / ACCESSWIRE / July 8, 2022 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today... 
From enVVeno Medical Corporation
Via AccessWire
News headline image
enVVeno Medical Reports First Quarter 2022 Financial Results and Provides Corporate Update
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From enVVeno Medical Corporation
Via AccessWire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Vallon Pharmaceuticals (NASDAQ:VLON) shares moved upwards by 94.7% to $2.2 during Friday's pre-market session. The company's market cap stands at $14.9 million. 
Via Benzinga
News headline image
enVVeno Medical Announces New U.S. VenoValve(R) Patent
- Expanding patent portfolio bolsters protection of the Company's lead product -The VenoValve is a potential first-in-class treatment for patients suffering from Chronic Venous Insufficiency (CVI) of... 
From enVVeno Medical Corporation
Via AccessWire
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 38.3% to $1.66 during Monday's regular session. The current volume of 3.5 million shares is 142.9% of TC... 
Via Benzinga
News headline image
50 Biggest Movers From Yesterday ↗
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron.... 
Via Benzinga
News headline image
enVVeno Medical Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
- Ended the Year With $55 Million in Cash Expected To Fund Operations Through the End of 2024 Including Release of Topline Pivotal Trial Data - Nine (9) VenoValve Surgeries Successfully Completed and... 
From enVVeno Medical Corporation
Via AccessWire
News headline image
One-Year VenoValve(R) Data Published in Peer-Reviewed Journal, Vascular and Endovascular Surgery
- Previously announced promising results from the first-in-human study demonstrated sustained safety and effectiveness of the VenoValve at 1-year post-implantation - The VenoValve is currently being... 
From enVVeno Medical Corporation
Via AccessWire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.